Therapeutic Promise of the Microbiome: The Dr. Paul Janssen Award Symposium
Sprecherin: Ruth Ley (Max-Planck-Institut für Biologie)
Datum & Uhrzeit: 09.02.2023, 9 Uhr - 12:30 Uhr
Über die Veranstaltung:
Considered the "father of human microbiome research", Dr. Jeffrey Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis, played a foundational role in this emerging field and shaped our current understanding of the role of microbial communities in human health and disease. His fundamental work uncovered the physiologic underpinnings of mammalian gut-microbial community-host interactions. His discoveries led to a novel understanding of the influence of the gut microbiota on nutritional status, which has profound therapeutic potential for two pressing global health challenges – obesity and its associated metabolic abnormalities, and childhood undernutrition. Growth and healthy development can be restored in undernourished infants and children via targeted repair of disrupted microbial communities in the gut.
Recognizing the impact of his revolutionary insights, Dr. Gordon has been awarded the annual Dr. Paul Janssen Award for Biomedical Research. This half-day virtual symposium, "Therapeutic Potential of the Microbiome: Dr. Paul Janssen Award Symposium," will celebrate his pioneering work and is a must-attend event for researchers in medicine, biological chemistry, molecular biology, and pharmacology. Following Dr. Gordon's award lecture, fellow prominent scientists will discuss several aspects of modern microbiome research, from basic biology to the translational implications for human health and disease. Symposium registration is complimentary. However, pre-registration is necessary to receive access to the live stream.
Mehr Informationen zur Veranstaltung und Registrierung finden Sie hier: Anmeldung